Indonesia to inject $1.1 billion into health insurer BPJS Kesehatan

By Reuters News

JAKARTA, Sept 29 (Reuters) - Indonesia's government will inject 20 trillion rupiah ($1.11 billion) into health insurer BPJS Kesehatan to help the state agency cover its deficit in 2026, according to a government statement.

  • BPJS Kesehatan has 285 million policyholders, making it one of the biggest single-payer health insurance providers in the world, but the agency often runs into financial problems.

  • So far this year it has collected 118 trillion rupiah in revenues, below the 132 trillion rupiah it has paid out in medical claims, its chief executive Priharti Pujowaskito was quoted as saying, according to the statement released by the president's office on Monday.

  • The government cash injection will take place in October and November and it will use existing funds from the 2026 state budget, Finance Minister Suahasil Nazara said in the statement.


($1 = 17,990 rupiah)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.